| scholarly article | Q13442814 |
| P50 | author | François Regoli | Q92819140 |
| Tiziano Moccetti | Q114418515 | ||
| Francesco F Faletra | Q114418527 | ||
| Catherine Klersy | Q43005750 | ||
| Angelo Auricchio | Q67189504 | ||
| P2093 | author name string | Jorge A Salerno-Uriarte | |
| Helmut U Klein | |||
| Luigi Inglese | |||
| Cecilia Fantoni | |||
| Antonio Sorgente | |||
| Santi Raffa | |||
| Massimo Baravelli | |||
| Ali Ghanem | |||
| P2860 | cites work | The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus | Q28190307 |
| Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction | Q28208692 | ||
| Prediction of creatinine clearance from serum creatinine | Q29615603 | ||
| Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction | Q33182324 | ||
| Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis | Q33542625 | ||
| Diabetes mellitus and congestive heart failure. Further knowledge needed | Q33635972 | ||
| Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure | Q34386004 | ||
| The effect of cardiac resynchronization on morbidity and mortality in heart failure | Q34400885 | ||
| Cardiac resynchronization in chronic heart failure | Q34524008 | ||
| Functional class in patients with heart failure is associated with the development of diabetes | Q34532622 | ||
| Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health | Q34913872 | ||
| Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry | Q36089085 | ||
| The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy | Q36400323 | ||
| Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy | Q36738707 | ||
| Diabetes and cardiovascular disease. The Framingham study | Q41509493 | ||
| The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group | Q42556789 | ||
| Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure. | Q43711828 | ||
| Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors | Q43720030 | ||
| Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial | Q43903128 | ||
| Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators | Q44086151 | ||
| A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes | Q44231078 | ||
| Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus | Q44693672 | ||
| Role of diabetes in congestive heart failure: the Framingham study | Q44758886 | ||
| Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. | Q44844669 | ||
| Vagolytic effect of diabetes mellitus. | Q48311757 | ||
| Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy. | Q51083978 | ||
| Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. | Q51147178 | ||
| Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. | Q51321668 | ||
| Comparison of effectiveness of cardiac resynchronization therapy in patients with versus without diabetes mellitus. | Q51422399 | ||
| Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. | Q51554248 | ||
| Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). | Q51554689 | ||
| In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. | Q51559558 | ||
| Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. | Q51630556 | ||
| Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure | Q57630980 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 298-307 | |
| P577 | publication date | 2008-03-04 | |
| P1433 | published in | European Journal of Heart Failure | Q5017954 |
| P1476 | title | Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy | |
| P478 | volume | 10 |
| Q26774376 | Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes |
| Q33621367 | Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome |
| Q35055236 | Cardiac resynchronization therapy in the cardiorenal syndrome |
| Q84949617 | Cardiac resynchronization therapy is effective even in elderly patients with comorbidities |
| Q39037093 | Co-Morbidities and Cardiac Resynchronization Therapy: When Should They Modify Patient Selection? |
| Q97545237 | Differential effect of cardiac resynchronization therapy in patients with diabetes mellitus: a long-term retrospective cohort study |
| Q51097799 | Effect of cardiac resynchronization therapy in patients with diabetes randomized in EchoCRT. |
| Q34815160 | Event-free survival following CRT with surgically implanted LV leads versus standard transvenous approach |
| Q43905899 | Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people |
| Q36128657 | Impaired Diastolic Recovery after Acute Myocardial Infarction as a Predictor of Adverse Events |
| Q34514408 | Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices |
| Q28081991 | Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis |
| Q36720290 | Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapy |
| Q90483522 | Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry |
| Q42209367 | Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes |
| Q33880742 | Sex-specific mortality differences in heart failure patients with ischemia receiving cardiac resynchronization therapy |
| Q40804025 | Sudden cardiac death in diabetes mellitus |
| Q58756665 | Type 2 diabetes is independently associated with all-cause mortality secondary to ventricular tachyarrhythmias |
| Q36355540 | Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure |
Search more.